Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18268
Country/Region: Haiti
Year: 2017
Main Partner: Catholic Medical Mission Board
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $5,600,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $788,864
Care: TB/HIV (HVTB) $348,467
Care: Pediatric Care and Support (PDCS) $74,840
Testing: HIV Testing and Counseling (HVCT) $1,156,512
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $389,717
Treatment: Adult Treatment (HTXS) $2,662,724
Treatment: Pediatric Treatment (PDTX) $178,876
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 32
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 4
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 32
GEND_GBV Number of people receiving post-GBV care 2018 36
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 117,613
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 3,617
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 2,413
HTS_TST Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Female, Negative 2018 9
HTS_TST Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Male, Negative 2018 6
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 97
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 64
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 19,128
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 12,750
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 600
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 398
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 7,990
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 5,325
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 17,498
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 11,666
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 597
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 398
HTS_TST Sum of Test Result disaggregates 2018 3,288
HTS_TST_POS By Test Result: Positive 2018 3,288
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 295
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 196
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 485
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 320
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 61
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 40
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 94
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 62
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 671
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 448
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 15
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 9
PMTCT_ART Already on ART at beginning of current pregnancy 2018 232
PMTCT_ART New on ART 2018 285
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 517
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 27,742
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 515
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 227
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 274
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 8
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 6
PMTCT_STAT By Age (Numerator): Unknown Age 2018 544
PMTCT_STAT By Number of known positives: Unknown Age 2018 285
PMTCT_STAT By Number of new negative: Unknown Age 2018 27,190
PMTCT_STAT By Number of new positives: Unknown Age 2018 267
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 27,742
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 28,599
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 12
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 111
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 7
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 83
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 213
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 213
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 12
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 111
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 7
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 83
TB_PREV By Age/Sex (Numerator): <15, Female 2018 124
TB_PREV By Age/Sex (Numerator): <15, Male 2018 143
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 1,395
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 854
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 2,516
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 2,791
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 136
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 86
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 1,623
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 946
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 77
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 736
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 49
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 489
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,351
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,406
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 85
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 763
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 53
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 505
TX_CURR Aggregated Age/Sex: <15 Female 2018 651
TX_CURR Aggregated Age/Sex: <15 Male 2018 436
TX_CURR Aggregated Age/Sex: 15+ Female 2018 6,580
TX_CURR Aggregated Age/Sex: 15+ Male 2018 4,391
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 12,227
TX_CURR Sum of Aggregated Age/Sex <15 2018 1,087
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 10,971
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 12,058
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 71
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 71
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 1,404
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,016
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 2,562
TX_NEW Pregnancy status 2018 285
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 2,562
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 12,233
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 9,172
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 478
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 50
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 298
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 33
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 4,724
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 526
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 2,758
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 305
TX_PVLS Numerator: Indication: Routine 2018 8,256
TX_PVLS Numerator: Indication: Targeted 2018 916
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 520
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 639
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 70
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 399
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 44
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 6,295
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 700
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 3,676
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 410
TX_PVLS_den Denominator: Indication: Routine 2018 9,160
TX_PVLS_den Denominator: Indication: Targeted 2018 1,113
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 477
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 59
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 40
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,226
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 809
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 2,135
TX_RET Numerator by Status: Pregnant 2018 307
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 2,791
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 84
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 56
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,675
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 976
TX_RET_den Denominator by Status: Pregnant 2018 307
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 10,693
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 22
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 14
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 8
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 639
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 397
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 6,098
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 3,559
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 1,070
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 1,070
TX_TB_den Denominator: By Screen Result: Negative 2018 8,552
TX_TB_den Denominator: By Screen Result: Positive 2018 2,140
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 2,140
Cross Cutting Budget Categories and Known Amounts Total: $74,840
Human Resources for Health $35,000
Food and Nutrition: Commodities $30,000
Renovation $9,840